- Zoledronic acid in treatment of osteoporosis2009 | First Faculty of Medicine
- Acid zoledron 1x yearly.2008 | First Faculty of Medicine
- Profound hypocalcaemia after zoledronic acid treatment2005 | First Faculty of Medicine
- Zoledronic acid - new treatment of Paget's bone disease2006 | First Faculty of Medicine
- Cost-effectiveness of denosumab versus zoledronic acid for preventing skeletal-related events in the Czech Republic2017 | Publication without faculty affiliation
- Ras Inhibition and the Survival Benefit Favoring Zoledronic Acid Compared With Denosumab in Patients With Multiple Myeloma Reply2011 | Publication without faculty affiliation
- Guidelines for diagnosing and therapy of postmenopausal osteoporosis II. Addendum.2010 | Faculty of Medicine in Hradec Králové
- Zoledronic acid add-on therapy for standard-risk Ewing sarcoma patients in the Ewing 2008R1 trial2023 | Second Faculty of Medicine
- Randomized, Double-Blind Study of Denosumab Versus Zoledronic Acid in the Treatment of Bone Metastases in Patients With Advanced Cancer (Excluding Breast and Prostate Cancer) or Multiple Myeloma2011 | Second Faculty of Medicine
- Bone metastases in urology2011 | Third Faculty of Medicine
- Response to Comparison of Teriparatide and Strontium Ranelate in Postmenopausal Women with Osteoporosis2009 | First Faculty of Medicine
- Denosumab for Men Receiving Androgen Deprivation Therapy for Prostate Cancer2009 | Third Faculty of Medicine
- New hormonal agents in castration-resistant prostate cancer2013 | First Faculty of Medicine
- Adherence to Aclasta(R) (SPC): results of a non-interventional clinical trial2014 | Faculty of Medicine in Hradec Králové
- Denosumab - a new potential effect of RANKL inhibitor2014 | Second Faculty of Medicine
- Basic treatment in multiple myeloma bone damage2016 | Faculty of Medicine in Pilsen
- Trial Watch: Immunogenic cell death inducers for anticancer chemotherapy2015 | Second Faculty of Medicine
- Prospects for the treatment of osteoarthritis2015 | First Faculty of Medicine
- Polyneuropathic Pain Therapy with a Patient Suffering from Generalized Castrate Resistant Prostate Cancer - Clinical Case Report2013 | Faculty of Medicine in Pilsen
- Evidence of novel miR-34a-based therapeutic approaches for multiple myeloma treatment2017 | Second Faculty of Medicine